| Milan, April 29th 2013 |
Infa Group attended the first CPhI Russia
Infa Group attended the first CPhI Russia, held in St. Petersburg on April 10 and 11, 2013.
|
| Milan, February 28th 2013 |
INFA GROUP announces today having formed a strategic alliance with ULKAR KIMYA for manufacturing of Generic API
INFA GROUP is pleased to announce today to have formed a strategic alliance for manufacturing some Generic API’s with ULKAR KIMYA, a member of the Turkish company Nobel Group.
|
| Milan, January 10th 2013 |
As of January 2013, Dr. Luca Mantovani has joined INFA Group SpA as CEO.
Luca Mantovani has previously worked for over 20 years with Gist-Brocades and DSM in several Senior Executive positions in different countries; last assignment was President of
|
| Milan, November 2012 |
US Food and Drug Administration General GMP Inspections
Infa Group is extremely pleased to announce that their three manufacturing units, Labochim and Sifavitor located in Italy and Derivados Quimicos SAU in Spain, have successfully completed US Food and Drug Administration General GMP Inspections this
|
| Robbinsville, NJ, November 1, 2012 |
DCAT Announces New Segment Vice President
The Drug, Chemical and Associated Technology Association (DCAT) is pleased to announce that Paolo Magrì, vice president, corporate business development, Infa, Inc., has been elected by the membership to serve as vice president-chemicals on DCAT’s Exe
|
|
 |
